Novel Structural Insights into Class I and II Histone Deacetylases

E-ISSN： 1873-4294|9|3|235-240

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.9, Iss.3, 2009-02, pp. : 235-240

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting class I histone deacetylases in cancer therapy

By Delcuve Geneviève P Khan Dilshad H Davie James R

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 1, 2013-01 ,pp. : 29-41

Informa Healthcare

Access to resources Recommend Favorite

Class I histone deacetylases 1, 2 and 3 are highly expressed in classical Hodgkin's lymphoma

By Adams Heiner Fritzsche Florian R Dirnhofer Stephan Kristiansen Glen Tzankov Alexandar

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 6, 2010-06 ,pp. : 577-584

Informa Healthcare

Access to resources Recommend Favorite

Targeting Histone Deacetylases in Neuroblastoma

Current Pharmaceutical Design, Vol. 15, Iss. 4, 2009-02 ,pp. : 436-447

Bentham Science Publishers

Access to resources Recommend Favorite

Assays for Histone Deacetylases

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 3, 2009-02 ,pp. : 227-234

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting histone deacetylases for heart failure

By Bush Erik W McKinsey Timothy A

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 7, 2009-07 ,pp. : 767-784

Informa Healthcare

Access to resources Recommend Favorite